Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 751.11

-2.6%

Jan 28 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (91)	5/3/1997 3:34:00 PM
From: Miljenko Zuanic	of 3559

Rick, Glad that you correct me regards TKTX. I didn't checked last night and this morning I sow that I misunderstand part of the questions. CNTF is on trial, no BDNF. Acquisition of the Syntex amgn got in possession patent covering moc for CNTF. Regn has patent covering receptor for CNTF. Also, before Syntex acquisition, regn and Syntex was in patent dispute regarding the moc patent. I thing, for now, this litigation is on hold, and regn has back-fire opportunity if amgn move to far from their partnership. Ctii will have (IMO) to license right from amgn and regn. This will be very difficult under current condition. Developing implant-CNTF for ALS they tested their technology in field. With current development in research for neuroprotective/grow factors it seams that combination of two or three will have better chance. This is regn Oxokime (combination of the CNTF and NGF) and ctii/gne NT-4/5 + CT-1 (chimeric CNTF). The future is on delivery method for large peptide and/or small chimirc molecule (regn-pcop). Regards the ARQL, their secondary offering is to rise cash which they need for expansion-acquisition of the smaller collaborators. Large library of the organic molecules needs biological targets and assays. mz

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next